Stony Brook University Hospital
Stony Brook, New York, 11794, United States
NCT Number: NCT04532177
This is a prospective pilot study investigating the safety and efficacy of stereotactic body radiation therapy (SBRT) as a treatment for breast cancer in patients who do not get surgery. The study will accrue 15 patients who will be treated to a dose of 40 Gy over the course of 5 fractions in the Stony Brook University Hospital Department of Radiation Oncology. The subjects will then have a follow up time of 5 years.
This study is active but is not currently recruiting participants.
Notify Me18 year and older
All sexes
Interventional
Not applicable
Stony Brook, New York, 11794, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
fractionated linear accelerator based SBRT to 40 Gy in 5 fractions
Time frame: 5 years
Rates of acute and late grade 3 or greater toxicity
Time frame: 5 years
Time frame: 5 years
Progression-free survival and overall survival
Stony Brook University
Other
Prospective Pilot Study of Stereotactic Body Radiation Therapy (SBRT) for Invasive Breast Cancer Patients Not Undergoing Definitive Surgery
Acronym: SBRT BREAST
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05715255
Breast Cancer, Breast Diseases
Phoenix, Arizona, United States
View Trial DetailsNCT05896189
Breast Cancer, Breast Diseases
Anchorage, Alaska, United States
View Trial DetailsNCT02942355
Breast Cancer, Breast Diseases
Charlotte, North Carolina, United States
View Trial DetailsNCT04461808
Breast Cancer, Breast Diseases
Reggio Emilia, Italy
View Trial Details